Sezzle Still Looks Attractive: A Fresh, Data-Driven Look
Sezzle continues to gain traction in a competitive BNPL market. This article examines why sezzle still looks attracti...
What To Include In Your Investment Portfolio
Curious about your investment portfolio? Discover what to include to ensure a balanced and profitable mix of assets.
23,656 articles
Tired Bubble Yet? Here’s a Real Solution to a Real Problem
As AI stocks cool, a rotation toward durable, revenue-generating assets accelerates. A new wheel technology startup i...
Greg Abel Already Reshaping Berkshire Hathaway Playbook
Greg Abel is stepping into Warren Buffett’s shoes with a plan that could redefine Berkshire Hathaway’s approach. This...
Invested $1,000 McDonald’s Starbucks: A Decade of Gains
A look at how a $1,000 stake in McDonald’s versus Starbucks would have evolved over the past decade, with today’s mar...
Economy Losing Steam After 57K Jobs in June, AI Bets
June payrolls rose just 57,000, signaling softer momentum. Yet three AI-driven stocks offer durable upside as corpora...
Income Built Bear Markets: SPHD in Retirement Portfolios
In a choppy market, SPHD delivers income built bear markets through a defensive mix of high-dividend, low-volatility ...
What Betting Markets Really Think About Stripe, Discord IPOs
Prediction markets show divergent odds for Stripe, Discord, and Anduril IPOs as of July 2026. Traders weigh S-1 timin...
These Stocks Now, Hold: 3 Long-Term Picks for Retirement
Three durable businesses stand out for a buy-and-hold approach as markets adjust to AI-driven demand and steadier gro...
Cathie Wood Just Bought SpaceX Dip Again, Alibaba Trimmed
ARK Invest doubled down on SpaceX after a market pullback, funding the move by trimming Alibaba. The trade underscore...
Wall Street Predicts These 3 AI Stocks May Double by 2030
Wall Street predicts these three AI stocks could double within four years as demand for AI infrastructure and memory ...
Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Nucor Upgraded by UBS to Buy with $190 Target
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status